AI-Driven Innovation to Enhance Stroke Treatment and Outcomes

Aidoc, a global leader in healthcare AI, has partnered with Circle Cardiovascular Imaging (Circle CVI) to enhance stroke care with AI-powered ASPECTS scoring. By integrating Circle CVI’s StrokeSENS ASPECTS into Aidoc’s industry-leading, AI-powered Full Brain Solution, this collaboration brings a comprehensive AI-driven approach to stroke care, enabling clinicians to make faster, more informed decisions and provide rapid life-saving treatment to patients.

Advancing Stroke Diagnosis with AI

Stroke is one of the most time-critical medical emergencies — every minute can mean the difference between recovery and permanent disability. The Alberta Stroke Program Early CT Score (ASPECTS), recommended by the European Stroke Organisation (ESO), is a widely used system to evaluate early ischemic changes. Upon receiving a patient scan, clinicians — radiologists, neurologists and emergency physicians — manually analyse the images, culminating in a score that informs a patient’s eligibility for treatments such as thrombolysis or mechanical thrombectomy.

However, manual scoring is time-consuming and prone to human error, especially when clinicians are under pressure to act quickly. StrokeSENS ASPECTS addresses these challenges by automating the scoring process, enabling enhanced accuracy, efficiency, and consistency in stroke assessments. This, in turn, may reduce time-to-treatment and improve patient outcomes.

“StrokeSENS ASPECTS provides clinicians with advanced insights that have been shown to increase the reliability and accuracy of ASPECTS reads, enabling clinicians to quickly identify patients who may benefit from live-saving treatment,” said Erkan Akyuz, CEO of Circle CVI. “Partnering with Aidoc to provide a comprehensive Stroke AI solution is a big step forward in stroke care and further delivers on our mission to enhance healthcare outcomes for vascular disease.”

A Comprehensive AI-Powered Stroke Solution: The Aidoc Difference

Aidoc’s Full Brain AI Solution is trusted by hospitals worldwide to prioritise suspected stroke cases, streamline care coordination, and support patient follow-up. Seamlessly delivered through its award-winning aiOS™, it automatically analyses all relevant scans and alerts clinicians about suspected vessel occlusions, including large and medium vessel occlusions (LVOs and MeVOs) in both the anterior and posterior circulation.Through its secure mobile app, stroke teams receive real-time notifications, enabling faster decision-making and treatment.

The integration of AI-powered ASPECTS scoring brings several key clinical benefits. The system delivers automated ASPECTS results to PACS and mobile devices in minutes from CT acquisition, allowing for advanced stroke assessment in the time-critical window. StrokeSENS ASPECTS enhances reader performance and helps standardize ASPECTS reads with improved sensitivity (+9.7%), specificity (+1.6%), and inter-reader agreement (+28%), as demonstrated in a Diagnostic Reader Study1. These improvements reduce subjectivity and ensure more consistent, reliable stroke evaluations. As a result, clinicians are empowered to make quicker, data-driven decisions that directly enhance patient outcomes.

Driving AI Adoption in Stroke Care

The partnership between Aidoc and Circle CVI comes at a pivotal time as AI adoption in stroke care expands across Europe. The ESO recommends ASPECTS scoring to assist in identifying candidates for mechanical thrombectomy, reinforcing its importance in clinical decision-making. By integrating AI-powered ASPECTS scoring with its neurovascular suite, Aidoc is aligning with these best-practice guidelines, enhancing stroke workflows, and supporting clinicians with rapid, actionable insights.

“Integrating Circle CVI’s StrokeSENS ASPECTS solution into our Full Brain Solution marks a major leap forward in stroke care,” said Alexander Böhmcker, VP Europe at Aidoc. “By combining the strengths of Aidoc’s aiOS™ platform with AI-powered ASPECTS scoring, we’re equipping clinicians with faster, more reliable insights — when every second counts. This partnership is a powerful step toward more standardised, data-driven stroke diagnosis and treatment across Europe.”

As AI-powered ASPECTS scoring gains prominence in stroke care, its integration with Aidoc’s neurovascular suite ensures greater speed, consistency, and accuracy in stroke assessments. This collaboration positions both companies at the forefront of an evolving landscape, driving innovation and improving patient outcomes across Europe.

About Aidoc

Aidoc is a pioneer in clinical AI. We focus on aiding and empowering healthcare teams to optimise patient treatment, which results in improved economic value and clinical outcomes. Aidoc’s clinically proven AI solutions eliminate silos, increase efficiencies and improve outcomes by delivering critical information when and where care teams need it leading to immediate collective action. Built on Aidoc’s proprietary aiOS™, we analyse and aggregate medical data to enable care teams to operationalise the unexpected and work seamlessly with a continued focus on the patient. Aidoc AI is always on, running in the background to change the foreground.

About Circle CVI

Circle Cardiovascular Imaging (Circle) is a Canadian-based company that was founded in 2007, established with the aim of developing innovative software solutions to enhance cardiovascular and cerebrovascular imaging analysis and improve patient care. Circle CVI's imaging platform provides best-in-class image reading and reporting for quantitative and qualitative assessment of cardiac MR, cardiac CT, and neuro CT.

At the heart of everything we do is our unrelenting drive to continually offer better solutions for healthcare providers that improve healthcare outcomes. This fuels our creativity, informs our decisions and is the reason we are passionate about our work. Our roots are medical and digital, our passion is contagious, and our people are amongst the best.

Annually, millions of medical imaging exams – in over 1700 hospitals and in more than 90 countries – are estimated to be interpreted using cvi42. For additional information, please visit www.circlecvi.com or contact: marketing@circlecvi.com

References:

1Unpublished data from Multi-reader Multi-case Pivotal Reader Study used for regulatory clearance.

*Disclaimer: StrokeSENS ASPECTS is not available for clinical use in all jurisdictions.